We cloned a gene smfY for multidrug efflux pump from chromosomal DNA of Serratia marcescens using drug-hypersensitive Escherichia coli KAM32 as the host, and characterized the pump. E. coli KAM32/pESM42 carrying the smfY showed significantly increased MICs of various drugs including DAPI, norfloxacin, benzalkonium chloride, acriflavine and ethidium bromide, compared with the control. We also detected energy-dependent ethidium and acriflavine efflux due to the SmfY. Sequence analysis revealed that the SmfY was a multidrug efflux pump of the MF (Major Facilitator) superfamily transporters. This is the first report of a multidrug efflux pump belonging to the MF superfamily in S. marcescens.
Serratia marcescens, a major cause of nosocomial disease, is associated with endocarditis, osteomyelitis, septicemia, wound infections, and urinary-and respiratory-tract infections.
3) The organism is particularly menacing and tenacious because of its intrinsic resistance to antiseptics and other antimicrobial agents. Actual contamination of antiseptics by this organism has been reported, [4] [5] [6] and its cells can survive and even grow in common hospital antiseptics such as benzalkonium chloride and chlorhexidine gluconate. Numerous reports have indicated that multidrug efflux pumps underlie this conspicuous antiseptic resistance, [7] [8] [9] [10] [11] [12] [13] [14] [15] and we have begun a systematic effort to identify the implied transport systems in the S. marcescens plasma membrane. We have previously cloned several genes related to multidrug resistance, from the chromosome of a clinical isolate of S. marcescens, 10, 16) and we report here the novel properties of one multidrug efflux transporter, designated SmfY, which belongs to the MF (Major Facilitator) superfamily of transport proteins.
MATERIALS AND METHODS

Cloning of Multidrug Efflux Transporter Genes from S. marcescens
The clinical isolate NUSM8903 of S. marcescens (generously provided by Dr. Yoshichika Arakawa, The National Institute of Infectious Diseases, Tokyo, Japan) was used as the source of chromosomal DNA.
16) The strain NUSM8903 showed relatively high MIC values of several antimicrobial agents among our laboratory collection. 16) Those MIC values were different from those of strain NUSM8906 which we have previously used for gene cloning. 16) To clone other genes responsible for multidrug resistance, we used NUSM8903 in this report. E. coli KAM32, a strain lacking the bacterial multidrug efflux pumps AcrAB and YdhE, 17) and thus being drug hypersensitive, was used as host. S. marcescens chromosomal DNA was prepared by the method of Thomas. 18) DNA was partially digested with Sau3AI and fractionated by sucrose density gradient centrifugation, after which the fragments were ligated to plasmid vector pBR322, cut with BamHI. The resulting library was then transformed into E. coli KAM32, and transformants were selected for growth in the presence of 10 mg/ml of ethidium bromide or 0.5 mg/ml of 4Ј,6-diamino-2-phenylindol (DAPI).
Determination of Minimum Inhibitory Concentration (MIC)
The MICs of various antimicrobial agents were determined in Mueller-Hinton broth (Difco) containing each compound in a twofold serial dilution series. The cells were incubated in the test medium at 37°C for 24 h, and growth was examined visually. The MIC of each compound was defined as the lowest concentration that prevented visible growth.
Evaluation of Ethidium and Acriflavine Transport Activities E. coli KAM32/pBR322 (control) and E. coli KAM32/pESM42 (carrying the smfY) were used for these assays. Both assays were performed as described previously. 10, 17) Acriflavine (final 1.25 mg/ml) or ethidium bromide (final 20 mM) was added to initiate drug accumulation, after equilibration of the cell suspensions at 37°C. The proton conductor CCCP (carbonylcyanide m-chlorophenylhydrazone, 30 mM) was subsequently added, to deenergize cell membranes.
Others The nucleotide sequence data reported in this paper have been deposited in the DDBJ, EMBL, and GenBank sequence databases, with the accession number AB251607.
RESULTS AND DISCUSSION
Cloning of the smfY Gene As a result for the cloning, sixteen resistant colonies were amplified, and plasmid isolated from them. Two plasmids included the gene sdeXY, which we have reported previously, 10) and three of the remaining plasmids were found to possess a singular region of the chromosomal DNA, as judged by restriction mapping. One of these plasmids, pESM41, possessed the shortest DNA insert from S. marcescens. Since the deletion plasmid pESM42 constructed from pESM41 conferred resistance to 19) SmvA of Salmonella enterica serovar Typhimurium, 20) LfrA of Mycobacterium smegmatis, 21) SgcB of Streptomyces globisporus, 22) VarS of Streptomyces virginiae 23) and QacA of Staphylococcus aureus, 24) respectively. (The similarity of SmfY to these same cognate proteins-allowing conservative substitutions-is 80, 80, 80, 77, 77 and 77%, respectively.) Since almost all defined motifs of the MF superfamily 25) are conserved in the SmfY protein, we classified SmfY as a member of MF superfamily.
Characterization of Multidrug Efflux Transporter SmfY
The substrate specificity of SmfY was investigated by measuring MICs of several antiseptics and many antimicrobial agents with twofold serial dilution method, acting on E. coli KAM32/pESM42 (carrying smfY) and E. coli KAM32/pBR322 (control). E. coli KAM32/pESM42 showed significantly increased MICs for DAPI, norfloxacin, benzalkonium chloride, acriflavine, ethidium bromide, tetraphenylphosphonium chloride (TPPCl), methyl viologen and Hoechst 33342, compared with the control, as is documented in Table 1 . The substrate specificity observed for SmfY proved very similar to that already reported with KmrA and SmvA. 19, 20, 26) Especially importantly, SmfY conferred resistance to the common antiseptic benzalkonium chloride. Some clinical isolates of S. marcescens which showed the resistance to benzalkonium chloride have been reported. 4, 6) It is possible that SmfY plays an important role in the resistance to benzalkonium chloride in those isolates of S. marcescens.
To confirm experimentally that SmfY is, in fact, a drug efflux transporter, we measured the movement of two substrates for the SmfY from cells of E. coli KAM32/pESM42 and E. coli KAM32/pBR322 (control). As demonstrated in Fig. 1A , accumulation of acriflavine by cells of the strain expressing smfY (KAM32/pESM42) was lower than accumulation by control cells (KAM32/pBR322) under energized conditions, but accumulation was low-and equivalent in both strains-under deenergized conditions (after addition of CCCP). Similar experiments were conducted with ethidium bromide (20 mM), and again, accumulation by KAM32/ pESM42 was lower than by KAM32/pBR322 (Fig. 1B) , for energized cells, but was equivalent in deenergized cells. Thus, energy-dependent efflux of both ethidium and acriflavine can be inferred for cells of E. coli KAM32, when they are expressing the S. marcescens protein SmfY.
Judging from the genome sequence information on S. marcescens Db11 (ftp://ftp.sanger.ac.uk/pub/pathogens/sm/), thirty-eight genes for multidrug efflux transporters and pumps are present in that organism. We have now cloned several genes for drug transporters or pumps, 16) a reasonable start on the systematic analysis of the whole set of multidrug transporting proteins in this microorganism. 17) The upward deflection in panel B indicates accumulation of ethidium. 10) Trace (a), E. coli KAM32/pBR322 (control). Trace (b), E. coli KAM32/pESM42 (expressing smfY).
